Kisspeptin Interactions: Alcohol, Caffeine, Food & Other Compounds in the Literature

How researchers frame "interactions" with kisspeptin

Kisspeptin is a hypothalamic neuropeptide that acts upstream of gonadotropin-releasing hormone (GnRH) neurons, and a 2016 review in Nature Reviews Endocrinology described kisspeptin-expressing neurons as central to the control of GnRH neuron activity, puberty onset and fertility (PMID 27199290). A 2025 review in Physiological Reviews surveyed kisspeptin and neurokinin B signalling and their roles in reproductive health, reflecting how much of the field is organised around the neuroendocrine axis rather than around drug-combination pharmacology (PMID 39813600).

That framing matters for interaction questions. In pharmacology, an "interaction" usually means one substance changing the absorption, metabolism or effect of another, tested by co-administration. In the kisspeptin literature summarised here, the studies instead ask how states — energy deficit, obesity, stress, sex-steroid feedback, chemical exposure — modulate kisspeptin neurons and their downstream output. Those are physiological modifiers, not classical drug–drug interaction data, and this page keeps the two categories separate.

Alcohol and kisspeptin: what the literature covers

No study in the verified evidence set for this page examined alcohol together with kisspeptin. There is no reported dose, no reported effect size and no reported adverse event for that combination in any of the papers cited here. That absence is stated plainly rather than filled in with inference.

Mechanistic reasoning (labelled as reasoning, not as a finding): researchers who discuss alcohol and reproductive hormones generally argue from the architecture of the axis — because kisspeptin neurons sit upstream of GnRH neurons and shape their activity, as the 2016 Nature Reviews Endocrinology review described (PMID 27199290), any exposure that alters hypothalamic signalling or gonadal steroid feedback is discussed as intersecting with that circuit in principle. The 2014 chapter on the endocrinology of the menstrual cycle set out how oestradiol and progesterone feed back on hypothalamic and pituitary output across the cycle, which is the framework such reasoning borrows (PMID 24782009). Reasoning of this kind generates hypotheses; it does not establish that alcohol changes kisspeptin signalling, and none of the cited papers tested it.

Caffeine and kisspeptin: what the literature covers

No study in the verified evidence set examined caffeine, coffee or other stimulants alongside kisspeptin. No dose, timing or outcome for such a combination appears in the cited literature.

Mechanistic reasoning (labelled as reasoning): discussions of stimulants and reproductive neuroendocrinology often route through stress physiology, because a 2022 review in Current Opinion in Pharmacology examined stress, kisspeptin and functional hypothalamic amenorrhoea and described kisspeptin neurons as a node where stress-related signals converge on reproductive output (PMID 36103784). That review concerned stress and functional hypothalamic amenorrhoea; researchers extrapolating from it to caffeine are making an inference beyond what the study reported.

Food, fasting and energy availability

This is the interaction domain with the most direct evidence. A 2025 review in Neuron examined hypothalamic mechanisms linking energy availability to puberty onset, describing how nutritional and metabolic signals are integrated by hypothalamic circuits that gate reproductive maturation (PMID 40179827). The same conceptual link appears in work on kisspeptin and obesity: a 2021 volume chapter in Advances in Experimental Medicine and Biology reviewed kisspeptin within what the authors called the genetic obesity interactome, connecting kisspeptin signalling to metabolic and body-weight regulation pathways (PMID 35023097).

On the deficit side, the 2022 review of stress, kisspeptin and functional hypothalamic amenorrhoea considered a condition in which reduced energy availability and psychological stress coincide with suppressed reproductive function, and discussed kisspeptin's role in that picture (PMID 36103784). Taken together, these papers describe food intake and energy status as physiological modulators of the kisspeptin–GnRH system rather than as substances that interact with an administered peptide (PMID 40179827, PMID 35023097).

What the cited literature does not contain is any fed-versus-fasted administration comparison for kisspeptin — no study here reported that a meal, a fast or a specific macronutrient changed the response to administered kisspeptin.

Body weight, metabolic states and PCOS

Polycystic ovary syndrome is frequently raised in questions about kisspeptin and metabolic context. A 2022 paper in the Journal of Assisted Reproduction and Genetics provided an overview of the etiology, genetics and immunology of PCOS (PMID 36190593), and a 2023 review in BMJ Medicine covered PCOS pathophysiology and therapeutic opportunities (PMID 37859784). Neither of those reviews is presented here as an interaction study; they describe a clinical context in which gonadotropin dynamics and metabolic features coexist, which is why the obesity-interactome chapter's framing of kisspeptin alongside metabolic pathways is relevant background (PMID 35023097).

Sex steroids and hormonal background

The hormonal environment is itself a modifier in this literature. The 2014 methods chapter on the endocrinology of the menstrual cycle described the cyclical oestradiol and progesterone changes and their feedback onto gonadotropin secretion (PMID 24782009), and the 2025 Physiological Reviews article reviewed how kisspeptin and neurokinin B signalling participate in reproductive control (PMID 39813600). A 2024 narrative review in Maturitas examined neuroendocrine mechanisms of mood disorders during the menopause transition, a period defined by changing sex-steroid signalling (PMID 39111089). These papers explain why investigators describe hormonal background — cycle phase, reproductive stage — as a variable that can shape kisspeptin-related measurements, rather than as a co-administered compound.

Other compounds researchers have studied around this pathway

Endocrine-disrupting chemicals

One verified paper did test an exogenous compound against this axis: a 2024 study in Science of the Total Environment investigated molecular effects of tetrachlorobisphenol A on puberty initiation in Wistar rats (PMID 37992829). Researchers in that study examined pubertal initiation endpoints in a rodent model, and the work is cited here as an example of chemical-exposure research touching pubertal onset — not as evidence about kisspeptin products, supplements or beverages in humans (PMID 37992829).

Neurokinin B signalling

Questions about combining kisspeptin with neurokinin B–targeted agents come up because the two peptides are discussed together. The 2025 Physiological Reviews article reviewed kisspeptin and neurokinin B and their roles in reproductive health (PMID 39813600). No co-administration trial pairing kisspeptin with a neurokinin-targeting compound appears in the verified set used for this page.

Glial signalling

A 2024 study in the Journal of Clinical Investigation reported that kisspeptin signalling in astrocytes modulated the reproductive axis, extending the cellular map beyond neurons (PMID 38861336). That finding is mechanistic rather than interaction-related, but it is often cited when researchers discuss why systemic factors might reach this circuit through more than one cell type (PMID 38861336).

Genetic background

A 2022 review in Clinical and Experimental Pediatrics examined genetic factors in precocious puberty (PMID 34665958), and the 2016 Nature Reviews Endocrinology review discussed control of puberty onset and fertility by GnRH neurons (PMID 27199290). Genotype is described in this literature as a source of between-individual variation in pathway function, which is part of why single-factor interaction claims are difficult to generalise (PMID 34665958).

Evidence map

Adverse events in interaction contexts: What Studies Report

None of the papers cited on this page reported adverse events arising from combining kisspeptin with alcohol, caffeine, food, supplements or another named compound, because none of them tested such combinations. The 2025 Physiological Reviews survey of kisspeptin and neurokinin B addressed reproductive physiology and health rather than combination tolerability (PMID 39813600), and the rodent exposure study reported on pubertal initiation endpoints in Wistar rats rather than on human co-exposure outcomes (PMID 37992829). Absence of reported events in this set reflects absence of testing, not a tolerability conclusion.

Why the gaps persist

• Design priorities. Reviews in this set concentrated on circuit mechanisms and clinical physiology, such as GnRH neuron control of puberty and fertility (PMID 27199290) and astrocytic kisspeptin signalling (PMID 38861336).
• Confounded states. Energy deficit, stress and body weight travel together in human cohorts, which the functional hypothalamic amenorrhoea review discussed (PMID 36103784) and the obesity-interactome chapter framed genetically (PMID 35023097).
• Heterogeneous populations. PCOS reviews described varied metabolic, genetic and immunological features (PMID 36190593, PMID 37859784), complicating single-variable interaction designs.

This page is for educational purposes only and is not medical advice; consult a licensed physician about any health question, medication or hormone-related concern. Nothing here describes how any substance should be used, combined or timed.

References

• Control of puberty onset and fertility by gonadotropin-releasing hormone neurons (Nature Reviews Endocrinology, 2016)
• Kisspeptin and neurokinin B: roles in reproductive health (Physiological Reviews, 2025)
• Stress, kisspeptin, and functional hypothalamic amenorrhea (Current Opinion in Pharmacology, 2022)
• Feed or breed: Hypothalamic mechanisms linking energy availability to puberty onset (Neuron, 2025)
• Kisspeptin and the Genetic Obesity Interactome (Advances in Experimental Medicine and Biology, 2021)
• The endocrinology of the menstrual cycle (Methods in Molecular Biology, 2014)
• Neuroendocrine mechanisms of mood disorders during menopause transition: A narrative review and future perspectives (Maturitas, 2024)
• Kisspeptin signaling in astrocytes modulates the reproductive axis (The Journal of Clinical Investigation, 2024)
• A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS) (Journal of Assisted Reproduction and Genetics, 2022)
• Polycystic ovary syndrome: pathophysiology and therapeutic opportunities (BMJ Medicine, 2023)
• Genetic factors in precocious puberty (Clinical and Experimental Pediatrics, 2022)
• Molecular insights into the effects of tetrachlorobisphenol A on puberty initiation in Wistar rats (Science of the Total Environment, 2024)